Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: A real life experience

European Journal of Ophthalmology

Volumn 26, Issue 4, 2016, Pages 351-355

  Ozkaya, Abdullah ^a   Alagoz, Cengiz ^a   Alagoz, Nese ^a   Gunes, Hasan ^a   Yilmaz, Ihsan ^a   Perente, Irfan ^a   Yazici, Ahmet T ^a   Taskapili, Muhittin ^a  

^a Beyoglu Eye Training and Research Hospital   (Turkey)

Author keywords

Dexamethasone; Diabetic macular edema; Lens; Pseudophakia; Visual acuity

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

AGED; ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; PSEUDOPHAKIA; RETROSPECTIVE STUDY; SLIT LAMP; TONOMETRY; VISUAL ACUITY; VISUAL PROSTHESIS; COMPLICATION; DIABETIC RETINOPATHY; DRUG IMPLANT; GLAUCOMA; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEXAMETHASONE; DIABETIC RETINOPATHY; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PSEUDOPHAKIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR; VISUAL ACUITY;

EID: 84975148394     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000725     Document Type: Article

References (23)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report No. 4. Int Ophthalmol Clin. 1987;27: 265-272.
2. Jusufbegovic D, Mugavin MO, Schaal S. Evolution of controlling diabetic retinopathy: changing trends in the management of diabetic macular edema at a single institution over the past decade. Retina. 2015;35(5): 929-934.
3. Wells JA, Glassman AR, Ayala AR, et al; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13): 1193-1203.
4. Ishiko S, Ogasawara H, Yoshida A, Hanada K. The use of scanning laser ophthalmoscope microperimetry to detect visual impairment caused by macular photocoagulation. Ophthalmic Surg Lasers. 1998;29(2): 95-98.
5. Elman MJ, Bressler NM, Qin H, et al; Diabetic Retinopathy Clinical Research Network. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4): 609-614.
6. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46(4): 1440-1444.
7. Meyer CH, Klein A, Alten F, et al. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera. Retina. 2012;32(10): 2133-2140.
8. Merkoudis N, Granstam E. Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting. Eur J Ophthalmol. 2013;23(4): 558-563.
9. Capone A Jr, Singer MA, Dodwell DG, et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study). Retina. 2014;34(2): 342-351.
10. Panozzo G, Gusson E, Panozzo G, Dalla Mura G. Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol. 2015;25(4): 347-351.
11. Habot-Wilner Z, Sorkin N, Goldenberg D, Loewenstein A, Goldstein M. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema. Ophthalmologica. 2014;232(2): 77-82.
12. Bonfiglio V, Fallico MR, Russo A, et al. Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling. Eur J Ophthalmol. 2015;25(5): e98-e100.
13. Bonnin S, Dupas B, Sanharawi ME, et al. Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema. Eur J Ophthalmol. 2015;25(5): 448-453.
14. Miserocchi E, Modorati G, Pastore MR, Bandello F. Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis. Ophthalmologica. 2012;228(4): 229-233.
15. Zhioua I, Semoun O, Lalloum F, Souied EH. Intravitreal dexamethasone implant in patients with ranibizumab persistent diabetic macular edema. Retina. 2015;35(7): 1429-1435.
16. Gillies MC, Lim LL, Campain A, et al. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology. 2014;121(12): 2473-2481.
17. Haller JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6): 1134-1146.
18. Boyer DS, Yoon YH, Belfort R Jr, et al; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10): 1904-1914.
19. Giocanti-Aurégan A, Grenet T, Fajnkuchen F, Chaine G. [Impact of cataract surgery on central macular thickness in diabetic patients without diabetic retinopathy.] J Fr Ophtalmol. 2013;36(1): 35-40.
20. Horozoglu F, Yanyali A, Aytug B, Nohutcu AF, Keskinbora KH. Macular thickness changes after phacoemulsification in previously vitrectomized eyes for diabetic macular edema. Retina. 2011;31(6): 1095-1100.
21. Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. JAMA. 1963;185: 884-886.
22. Armaly MF. Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration. Arch Ophthalmol. 1966;75(6): 776-782.
23. Caillaux V, Valtot F, Souied EH, Mimoun G. Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion. Eur J Ophthalmol. 2015;25(5): 454-458.